A Leukocyte Esterase, Urine test checks for leukocyte esterase—an enzyme released by white blood cells (especially neutrophils) when they’re activated or break down. Because healthy urine is typically sterile and should not contain white blood cells, leukocyte esterase in urine acts as a marker of immune activity in the urinary tract. It’s commonly used as a frontline screen for urinary tract infection (UTI) or urinary inflammation.

Leukocyte esterase indicates white blood cells have entered the urinary tract to respond to infection or inflammation. In many cases, a positive leukocyte esterase result supports the suspicion of a bacterial UTI—especially when paired with symptoms like burning, urgency, frequent urination, pelvic discomfort, or cloudy/foul-smelling urine. It provides objective lab evidence that can help guide next steps, often alongside urine microscopy and urine culture.

A negative (or consistently negative/trace) leukocyte esterase result generally means there is no significant white blood cell activity in the urine, which is the expected healthy norm. This suggests the bladder, urethra, and kidneys are not showing lab signs of infection or inflammation at the time of testing. If symptoms are present despite a negative result, clinicians typically correlate with other urinalysis findings and clinical evaluation.

A positive leukocyte esterase result usually means white blood cells are present in urine (pyuria), most commonly due to a urinary tract infection. Typical UTI symptoms include burning during urination, urgency, frequent urination, pelvic discomfort, and cloudy or strong-smelling urine. In children, fever and irritability may be key signs. If a kidney infection is involved, symptoms can include fever, fatigue, or back/flank pain.

Leukocyte esterase testing can help identify urinary infections or inflammation early—before they ascend to the kidneys or cause serious complications. Untreated infections may progress to kidney infection, kidney scarring, or even bloodstream infection (sepsis). By flagging immune activity in the urinary tract, this test supports earlier evaluation and treatment, which helps protect long-term kidney health and reduce the risk of recurrent or worsening infections.

Leukocyte esterase is typically reported qualitatively as negative, trace, or positive. Negative is considered the healthy norm and indicates no significant white blood cells detected in urine. Trace may still be considered near-normal in some contexts, but because leukocyte esterase is a marker of white blood cell presence, any detectable level can warrant interpretation alongside symptoms, urine microscopy, and—when appropriate—urine culture to confirm infection.

Leukocyte esterase provides quick screening evidence that the immune system may be responding to urinary infection or inflammation. Clinicians commonly interpret it together with UTI symptoms and confirmatory testing such as urine microscopy and urine culture. This combined approach can guide whether antibiotics are appropriate, help target therapy based on culture results, and reduce unnecessary antibiotics when leukocyte esterase findings don’t match symptoms or when contamination is suspected.

False positives can occur when the urine sample is contaminated during collection, including contamination from vaginal discharge or skin sources. Certain medications and collection technique issues may also affect results. Because leukocyte esterase reflects white blood cell activity, contamination can mimic true urinary tract inflammation. For accurate interpretation, results are typically correlated with symptoms and other urinalysis components, and a urine culture may be used to clarify whether bacteria are present.

False negatives can happen if the urine is very dilute or if the infection is early and white blood cells haven’t accumulated to detectable levels. A negative leukocyte esterase does not always rule out infection when classic symptoms are present. Clinical correlation is important, and clinicians may rely on urine microscopy, repeat testing, or urine culture to better assess for UTI or other inflammatory conditions affecting the bladder or kidneys.

Pregnancy increases susceptibility to urinary infections, and asymptomatic UTIs can raise risks such as complications affecting mother and fetus (including risk tied to preterm labor in untreated cases). For people with recurrent positive tests or frequent UTIs, leukocyte esterase monitoring can help identify infections early and track response after antibiotics. Recurrent positives may also suggest the need to evaluate contributing factors like structural issues, immune compromise, or chronic kidney stress.